Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

T-cells and cancer cells

A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

Project to Sequence 20K Dog and Cat Genomes

Dog's nose

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

Infographic – Mixed Signals on 2022 Venture Funding

Chart: Venture funding by quarter through 2022

Total venture funds invested fell each quarter in 2022, from $163.1 billion in Q1 to $77.2 billion in Q4, which suggests continued declines into 2023. . . . → Read More: Infographic – Mixed Signals on 2022 Venture Funding

Skills That Help When Starting a Business

There are plenty of businesses that set up great products, yet fail because the owners weren’t great at decision-making or properly marketing what they’ve got. . . . → Read More: Skills That Help When Starting a Business

BioNTech to Provide Personal Cancer Immunotherapies in UK

Vials and bottles

The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030. . . . → Read More: BioNTech to Provide Personal Cancer Immunotherapies in UK

Biotech Alliance Creating Circular RNA Cancer Drug

Cancer on clipboard

A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug

Protein Chemistry Biotech Gains Collaboration, Venture Funds

DNA molecule model

An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds

Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization

SARS-Cov-2 virus

Findings from a clinical trial show an anti-inflammatory drug reduces new symptoms among people with Covid-19 infections and keeps them out of the hospital. . . . → Read More: Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization